Retrospective Cohort Study
Copyright ©The Author(s) 2023.
Artif Intell Gastrointest Endosc. Dec 8, 2023; 4(2): 18-26
Published online Dec 8, 2023. doi: 10.37126/aige.v4.i2.18
Table 1 Baseline patient demographics, procedure characteristics and detection rate for both conventional colonoscopy and Artificial Intelligence Assisted Colonoscopy

AIAC (n = 746)
CC (n = 2162)
Age, median (IQR)58.2 (47-69)60 (49-71)
Sex
Male359 (48.1)1034 (47.8)
Female387 (51.9)1128 (52.2)
Indication for colonoscopy
Symptoms292 (39.1)729 (33.7)
Surveillance201 (26.9)706 (32.7)
Positive FOBT128 (18.5)293 (13.6)
Other125 (16.8)434 (20.1)
Bowel Prep Quality
Not stated0 (0)1 (0.05)
Poor39 (5.2)107 (4.9)
Fair101 (13.5)225 (10.4)
Good514 (68.9)1582 (73.2)
Excellent92 (12.3)247 (11.4)
Caecum intubated733 (98.3)2104 (97.3)
Withdrawal time (min), median (IQR)13.31 (9.13-19.06)12.49 (8.38-19.0)
PDR620 (85.3)1596 (73.9)
Polyps removed
0176 (23.6)566 (26.2)
1126 (16.9)446 (20.6)
299 (13.3)325 (15.0)
381 (10.9)216 (10.0)
457 (7.6)128 (5.9)
552 (7.0)118 (5.5)
635 (4.7)84 (3.9)
729 (3.9)62 (2.9)
818 (2.4)38 (1.8)
912 (1.6)33 (1.5)
10-1952 (7.0)129 (6.0)
20-999 (1.2)17 (0.8)
Adenoma detection rate392 (52.6)1125 (52.1)
Villous histology26/392 (6.6)80/1125 (7.1)
HGD2.3/392 (9.0)43 (3.8)
Adenomas removed
0354 (47.5)1037 (48.0)
1167 (42.6)478 (42.5)
274 (18.9)232 (20.6)
339 (10.0)138 (12.3)
431 (7.9)88 (7.8)
522 (5.6)69 (6.1)
615 (3.8)33 (2.9)
710 (2.5)32 (2.8)
812 (3.06)22 (2.0)
95 (1.3)11 (1.0)
10-1917 (4.3)20 (1.8)
20-990 (0)2 (0.2)
Adenoma size
≤ 5 mm234 (59.7)683 (60.7)
5-10 mm101 (25.8)269 (23.9)
10-20 mm49 (12.5)126 (11.2)
≥ 20 mm8 (2.0)47 (4.2)
SSLDR130 (17.4)392 (18.1)
SSLs with Dysplasia1 (0.7)3 (0.7)
SSLs removed
165 (50)211 (53.8)
234 (26.2)86 (21.9)
312 (10)27 (6.9)
44 (3.1)16 (4.1)
≥ 512 (10.8)52 (13.2)
SSL size
≤ 5 mm58 (44.6)173 (44.1)
5-10 mm43 (33.1)118 (30.1)
10-20 mm23 (17.7)92 (23.5)
≥ 20 mm6 (4.6)9 (2.3)